INCYTE CORP
INCY · XNASCIK 879169fmd_1RZ25GA3EHS89VHT3XMZR3MQ0AServices · Services-Commercial Physical & Biological ResearchTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2026, 68 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1,106 | 1,536 | 1,882 | 2,159 | 2,667 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 |
| Cost of revenue | 58 | 79 | 94 | 114 | 131 | 151 | 207 | 255 | 312 | 372 |
| Gross profit | 1,048 | 1,457 | 1,788 | 2,045 | 2,535 | 2,835 | 3,188 | 3,441 | 3,929 | 4,769 |
| Research and development | 582 | 1,326 | 1,198 | 1,154 | 2,216 | 1,458 | 1,586 | 1,628 | 2,607 | 2,050 |
| Selling, general and administrative | 303 | 366 | 434 | 469 | 517 | 740 | 1,002 | 1,156 | 1,242 | 1,376 |
| Operating income | 145 | (243) | 129 | 402 | (264) | 586 | 579 | 621 | 61 | 1,515 |
| Interest expense | 39 | 7 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 2 |
| Interest and investment income | – | – | – | – | – | – | 40 | 158 | 129 | 106 |
| Other non-operating income (expense) | – | 17 | 32 | 52 | 23 | 11 | (1) | 14 | 13 | 25 |
| Income before taxes | 107 | (312) | 115 | 487 | (232) | 570 | 529 | 834 | 317 | 1,664 |
| Income tax expense | 3 | 1 | 6 | 40 | 63 | (378) | 188 | 237 | 284 | 378 |
| Net income from continuing operations | 104 | (313) | 109 | 447 | (296) | 949 | 341 | 598 | 33 | 1,287 |
| Net income | 104 | (313) | 109 | 447 | (296) | 949 | 341 | 598 | 33 | 1,287 |
| Net income to common shareholders | 104 | (313) | 109 | 447 | (296) | 949 | 341 | 598 | 33 | 1,287 |